You are here


Genome Canada’s model is premised on partnership. We leverage all of our investments in genomic research, technology and translation through co-funding with others.

In recent years, we have committed to increasing our co-funding leverage from a customary 1:1 ratio to 1:2 – requiring partners to contribute two-thirds of total project costs. This approach stretches every Canadian taxpayer dollars invested in Genome Canada further and stimulates greater investment in genomics research and development from the private sector, among other key partners.

Our Co-funding Ratio is Increasing